AI for complex diseases Robovision is developing AI applications for complex diseases, showcasing expertise in healthcare solutions that can be leveraged for partnerships with medical institutions or pharmaceutical companies.

Expansion plans in the US With recent investments totaling $42M aimed at expanding operations across the US, Robovision presents a sales opportunity for technology integrators, distributors, and businesses wanting to leverage AI vision intelligence solutions in the American market.

Industrial automation focus Having raised $42M to accelerate AI-powered industrial automation solutions, Robovision is positioned as a key player in this sector, creating opportunities for collaborations with manufacturing companies seeking advanced automation technologies.

Strategic partnerships in healthcare Given Robovision's ventures in developing AI platforms for medical image diagnostics in collaboration with organizations like NIH, sales professionals in the healthcare industry can explore partnership opportunities to integrate AI solutions for enhanced diagnostic capabilities.

Expertise in robotics and algorithms By teaming up with SEF to develop advanced robotics and algorithmic software, Robovision demonstrates proficiency in this space, offering potential sales prospects for companies looking to incorporate cutting-edge robotics technology into their operations.